Q4's results exhibited consistent organic revenue growth but it got hit by currency fluctuations and strategic divestitures.Medical technology specialist Medtronic (MDT -5.11%) released fourth-quarter and full-year data for fiscal 2024 on Thursday, May 23, that painted a nuanced financial picture.The company reported $8.59 billion in Q4 revenue which was up less than 1% year over year, yet it rose a robust 5.4% growth on an organic basis (growth not attributable to mergers and acquisitions). Medtronic's bus ...